Viral vector vaccines
Over the past two years, the SARS-CoV-2 pandemic has highlighted the impact that emerging pathogens can have on global health. The development of new and effective vaccine technologies is vital in the fight against such threats. Viral vectors are a relatively new vaccine platform that relies on reco...
Main Authors: | McCann, N, O'Connor, D, Lambe, T, Pollard, AJ |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elseveir
2022
|
Títulos similares
-
Clinical advances in viral-vectored influenza vaccines
por: Sebastian, S, et al.
Publicado: (2018) -
Clinical Advances in Viral-Vectored Influenza Vaccines
por: Sarah Sebastian, et al.
Publicado: (2018-05-01) -
Clinical development of viral vectored vaccines against MERS-COV
por: Ewer, K, et al.
Publicado: (2018) -
Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
por: Sheerin, D, et al.
Publicado: (2021) -
Viral vectors as vaccine platforms: from immunogenicity to impact
por: Ewer (nee Russell), K, et al.
Publicado: (2016)